Trial
NCT04693533
Fremanezumab, Migraine and Sleep
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Teva Pharmaceuticals USA
Condition
Migraine Disorders
Intervention
Fremanezumab Prefilled Syringe [Ajovy]
Why stopped
poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-27